Keyword: Emergent BioSolutions

News

Emergent BioSolutions Faces Shareholder Lawsuits

07.07.2021 -

In the aftermath of a far-reaching mix-up of Astra Zeneca’s Covid vaccine ingredients with those of Johnson & Johnson’s shot, US CDMO Emergent BioSolutions not only has...

News

Eastman Sells Rubber Additives to One Rock

14.06.2021 -

Eastman Chemical has agreed to sell several rubber additives lines and related technology assets of its tire additives business to an affiliate of One Rock Capital...

News

Emergent Ruined 60 Million J&J Vaccine Doses

14.06.2021 -

The (almost) worst-case scenario in the mix-up of Johnson & Johnson and AstraZeneca’s Covid-19 vaccine at the Baltimore, Maryland, plant of CDMO Emergent BioSolutions...

News

Emergent May Resume J&J Covid Shot Production Soon

01.06.2021 -

The US Food and Drug Administration will allow the restart of CDMO Emergent BioSolutions’ still shuttered Bayview plant in Baltimore, Maryland, within the next few days...

News

US Supplies of J&J Covid-19 Vaccine Dry up

17.05.2021 -

Problems at CDMO Emergent BioSolutions in the US state of Maryland and the resulting Food and Drug Administration shutdown of its Baltimore vaccine production facility...

News

J&J Signs two new Covid-Vaccine Pacts

05.05.2020 -

As part of a plan to establish a network of manufacturing partners to help boost capacity ahead of a potential FDA approval of a Covid-19 vaccine, US healthcare giant...

News

Revived Search for a TB Vaccine May Be About to Pay Off

01.02.2013 - After nearly 100 years, researchers could be on the verge of finding a vaccine that would eradicate tuberculosis infections, a scourge that kills 1.4 million people a year. Global...

News

U.S. Government Investment Gives Flu Vaccines a Shot in the Arm

19.01.2013 - Fighting the flu may soon get easier. As early as next year, more modern and more effective vaccines will hit the market, thanks to investments by the U.S. government and...